Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
doi: 10.3389/fnut.2023.1221438 Received 12 May 2023 Accepted 25 July 2023 Published 08 August 2023 Volume 10 - 2023 Edited by Rahele Ziaei, Isfahan University of Medical Sciences, Iran Reviewed by Prabu Paramasivam, University of New Mexico, United States
A comprehensive safety and tolerability study evaluated approximately 900 participants across six trials with the following protocols: Subcutaneous/Intravenous Protocols: Single doses ranging from 25 to 400 mcg/kg body weight were tested
In some embodiments, the MDT for poloxamer from a formulation or device described herein is at least 10 hours
Third-party tested, COA included
US$ 29.44
US$ 26.62
US$ 28.85
US$ 21.06
US$ 24.99
US$ 29.02
US$ 21.05
US$ 23.14
US$ 24.12
US$ 28.99
US$ 29.04
US$ 20.83
US$ 25.64
